Creative Educational Program Gets $100K Gift from Breakthrough Prize Winner
A UCSF graduate program in complex biology led by Joseph DeRisi, PhD, is being lauded for its creativity with a $100,000 gift.
University of California San Francisco
Give to UCSFA UCSF graduate program in complex biology led by Joseph DeRisi, PhD, is being lauded for its creativity with a $100,000 gift.
A UCSF-led team of scientists has discovered that a gene mutation found in some bladder cancers is indicative of low-risk tumors that are unlikely to recur or progress after surgery.
Through support from the Catalyst Awards, UCSF researcher Aditi Bhargava is working to develop a method for delivering small-molecules to a specific target group of cells for treatment of pain.
A UCSF opthamologist and bioengineer are collaborating to develop a tiny, flexible, implantable film that's able to deliver conventional medicines and also complex antibody-based drugs to treat eye diseases.
Often deadly “triple-negative” breast cancers might be effectively treated in many cases with a drug that targets a previously unknown vulnerability in the tumors, UCSF reports.
Brian Alldredge, associate dean for the UCSF School of Pharmacy for the past 12 years and a member of the faculty for 28 years, has been named Vice Provost for Academic Affairs.
UCSF researchers received six of 78 awards announced this week by the National Institutes of Health for innovative, high-risk, high-reward research.
In her annual State of the University address, Chancellor Susan Desmond-Hellmann highlighted UCSF's investments in its research, education and patient care to meet the challenges ahead.
A new link between meal times and daily changes in the immune system has been identified by UCSF researchers, and has led them to question assumptions about the roles of specific immune cells in infection and allergy.
Scientists from UCSF have identified a new way to manipulate the immune system that may keep it from attacking the body’s own molecules in autoimmune diseases such as type 1 diabetes, rheumatoid arthritis and multiple sclerosis.
UCSF will receive $4.5 million for a pilot project to assess whether large-scale gene sequencing can and should become a routine part of newborn testing.
A protein at the center of Parkinson’s disease research now also has been found to play a key role in causing the destruction of bacteria that cause tuberculosis.
An antihistamine discovered in the 1950s to treat itching may also prevent seizures in an intractable form of childhood epilepsy, according to researchers at UC San Francisco who tested it in zebrafish bred to mimic the disease.
A team of researchers at UCSF is incorporating genomics into a broad group of potential factors that can help clinicians better understand which patients are at greatest risk for persistent postsurgical pain and how to better prevent or treat it.
A multidisciplinary team at UCSF has significantly improved and shortened the application process for getting early-stage research off the ground.
Researchers have probed deep into the cell’s genome to begin learning the “grammar” that helps determine whether or not a gene gets switched on to make the protein it encodes, advancing efforts to use gene and cell-based therapies to treat disease.
An international study on epilepsy has uncovered 25 new mutations on nine key genes that could pave the way to develop precise therapies for a devastating form of the disorder during childhood.
An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial, UCSF and Yale University report.
Adenoviruses commonly infect humans, causing colds, flu-like symptoms and sometimes even death, but now UCSF researchers have discovered that a new species of adenovirus can spread from primate to primate, and potentially from monkey to human.